News
Stories about the companies we track, gathered daily from UK and European tech press and Google News. Headlines link to the original publisher.
23 storiesQureight ✕
Clear all- LeadershipCambridge Network, 13 days agoQureight appointed imaging CRO for Phase 3 SURPASS-IPF trial as partnership with Celea Therapeutics expands
- Partnerships & dealsBusiness Weekly, 14 days agoQureight chosen by Boston-based Celea Therapeutics as imaging CRO
- ExpansionSelect Science, 1 Sept 2026Qureight expands UK footprint for AI imaging
- ExpansionManufacturing Chemist, 20 Aug 2026Qureight opens London site to expand AI-powered imaging services for clinical trials
- ExpansionNews-Medical, 19 Aug 2026Qureight expands with addition of second site, to accommodate rapid growth and ongoing development of chest Foundation Model
- ExpansionBusiness Weekly, 18 Aug 2026Qureight expands UK operations with new Holborn office
- Fundingcambridgeindependent.co.uk, 6 Aug 2026Qureight’s Series B $20m to enhance Foundation Model’s AI-powered medical imaging
- FundingBusiness Weekly, 28 Jul 2026Qureight Secures $20m Series B to scale AI imaging tech for clinical trials
- OtherScientist Live, 18 May 2026Qureight imaging used in SSc clinical trial
- OtherNews-Medical, 13 May 2026Qureight to support Mediar Therapeutics' Phase 2 trial of MTX-474 in diffuse cutaneous Systemic Sclerosis
- Otherthe-scientist.com, 7 May 2026Qureight establishes Scientific Advisory Board focused on pulmonary hypertension
- Otherthepharmaletter.com, 13 Jan 2026Rebecca Simmons leaves quantum computing firm to become Qureight COO
- LeadershipCambridge Network, 12 Jan 2026Qureight appoints Rebecca Simmons as Chief Operating Officer
- OtherInside Precision Medicine, 17 Oct 2025Damian Doherty Chats with Qureight’s Simon Walsh, MBBS, PhD
- Othercambridgeindependent.co.uk, 19 Sept 2025Qureight celebrates astounding progress in new Cambridge HQ on Station Road
- OtherHealthInvestor UK, 2 Sept 2025Qureight: Craig Rhodes
- OtherImaging Technology News, 27 Aug 2025Qureight AI 3D Imaging Platform Selected for Phase 2 AURORA Study of CAL101
- ExpansionDrug Discovery News, 15 Jul 2025Qureight analyses of Insilico Medicine’s Phase IIa rentosertib data support preliminary efficacy results and future trial expansion
- Othercambridgeindependent.co.uk, 19 Jun 2025Qureight replaces placebo with AI in world-first study
- OtherDrug Discovery News, 18 Jun 2025Qureight’s synthetic study arms validate clinical efficacy in pioneering rare lung disease treatment
- OtherCambridge Independent, 7 May 2025Qureight’s platform deployed in Rein Therapeutics’ IPF trial
- Partnerships & dealsBusiness Weekly, 5 May 2025Rein Therapeutics and Qureight broaden life science collaboration
- OtherFirstWord Pharma, 1 May 2025Qureight and Rein Therapeutics team up to supercharge IPF research with AI-powered imaging
